cAMP crosses junctions
Regulatory T (T reg) cells that cozy up to other T cells send inhibitory molecules through cell-cell gap junctions, according to a new study by Bopp et al. (page 1303) .
Some thymus-born natural T reg cells need little more than direct contact with their T cell victims to suppress their immune functions. But the mechanism or molecule that controls this contactdependent inhibition has not yet been found.
One known potent immune suppressor is the intracellular second messenger cyclic adenosine monophophate (cAMP), which blocks T cell proliferation. cAMP levels are low in resting T cells and only marginally increase after activation. T reg cells, however, have constantly high levels of cAMP.
The team now shows that T reg cells use their abundant cAMP to flood conventional T cells and thereby shut them down. The cAMP transfer occurred through gap junctions, which formed upon contact between a T reg cell and an activated T cell. The subsequent increase in cAMP shut down T cell proliferation. cAMP transfer into activated T cells failed when gap junction formation was disrupted.
Together 
Vessel-widening by VEGF
A growth factor for blood vessels has also been touted as an inducer of lymph vessel growth. But Wirzenius et al. (page 1431) now find that, although the growth factor spurs the enlargement of existing lymph vessels, it does not induce the sprouting of new ones.
Lymph vessels are a follow-up act to blood vessels during embryogenesis. Vascular endothelial growth factor (VEGF) induces new blood vessel growth by binding to its receptor VEGFR-2 on vascular endothelial cells. VEGF-C and -D then kick off lymph vessel sprouting by binding to VEGFR-3 on lymphatic endothelial cells. But studies in mice that overexpress VEGF suggest that the two signaling pathways are not completely segregated. The abnormally large lymph vessels in these mice imply that VEGF somehow controls lymph vessel enlargement as well.
The team now finds that VEGFR-2 is also expressed on lymph vessels and induces their widening. But VEGF did not start lymph vessel growth anew: the missing lymph network of mouse embryos lacking VEGF-C and -D was not rescued by VEGF.
Lymphatic enlargement during inflammation helps immune cells accumulate at the site of injury or infection. But lymph vessels that don't later slim down increase the risk of chronic inflammation. Lymph vessel expansion is also dangerous during tumor growth in lymph nodes, as enlarged vessels act as highways for metastasizing tumor cells. Current antitumor strategies that target VEGF prevent blood vessel growth and thus nutrient supply to tumors. This study suggests that anti-VEGF treatment may also prevent tumor metastasis.
VEGF induces lymph vessel enlargement (top) but not the sprouting of new vessels (bottom).
Lymphoid thymic inducers (green) activate RANK to turn on Aire (red) in thymic cells (blue).
